Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Concetta Castilletti and Emanuele Nicastri.
Concetta Castilletti
Connection Strength
2.394
Emanuele Nicastri
  1. Comment on the Potential Risks of Sexual and Vertical Transmission of COVID-19. Clin Infect Dis. 2020 11 19; 71(16):2298.
    View in: PubMed
    Score: 0.229
  2. SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection. Ann Intern Med. 2020 08 04; 173(3):242-243.
    View in: PubMed
    Score: 0.219
  3. Prolonged detection of dengue virus RNA in the semen of a man returning from Thailand to Italy, January 2018. Euro Surveill. 2018 05; 23(18).
    View in: PubMed
    Score: 0.191
  4. Molecular Characterization of Autochthonous Chikungunya Cluster in Latium Region, Italy. Emerg Infect Dis. 2018 01; 24(1).
    View in: PubMed
    Score: 0.188
  5. Full-Length Genome Sequence of a Chikungunya Virus Isolate from the 2017 Autochthonous Outbreak, Lazio Region, Italy. Genome Announc. 2017 Dec 07; 5(49).
    View in: PubMed
    Score: 0.186
  6. Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017. Euro Surveill. 2017 Aug 24; 22(34).
    View in: PubMed
    Score: 0.183
  7. Enabling Rapid Response to the 2014-2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro Spallanzani. Adv Exp Med Biol. 2017; 972:103-122.
    View in: PubMed
    Score: 0.175
  8. Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient. J Cell Mol Med. 2021 May 25.
    View in: PubMed
    Score: 0.059
  9. Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach. Int J Infect Dis. 2021 Jun; 107:247-250.
    View in: PubMed
    Score: 0.059
  10. SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus. Viruses. 2021 04 10; 13(4).
    View in: PubMed
    Score: 0.059
  11. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. Int J Infect Dis. 2021 Apr; 105:532-539.
    View in: PubMed
    Score: 0.058
  12. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. J Infect. 2021 04; 82(4):58-66.
    View in: PubMed
    Score: 0.058
  13. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. 2021 04 01; 184(7):1821-1835.e16.
    View in: PubMed
    Score: 0.058
  14. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay. Viruses. 2020 10 20; 12(10).
    View in: PubMed
    Score: 0.057
  15. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):286.e7-286.e13.
    View in: PubMed
    Score: 0.057
  16. Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19. J Antimicrob Chemother. 2020 10 01; 75(10):2977-2980.
    View in: PubMed
    Score: 0.057
  17. Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response Kinetics. Open Forum Infect Dis. 2020 Oct; 7(10):ofaa403.
    View in: PubMed
    Score: 0.056
  18. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020 11; 27(11):3196-3207.
    View in: PubMed
    Score: 0.055
  19. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy. Clin Microbiol Infect. 2020 07; 26(7):954-956.
    View in: PubMed
    Score: 0.055
  20. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Euro Surveill. 2020 02; 25(8).
    View in: PubMed
    Score: 0.054
  21. Pulmonary Involvement during the Ebola Virus Disease. Viruses. 2019 08 24; 11(9).
    View in: PubMed
    Score: 0.052
  22. The Surveillance of Chikungunya Virus in a Temperate Climate: Challenges and Possible Solutions from the Experience of Lazio Region, Italy. Viruses. 2018 09 14; 10(9).
    View in: PubMed
    Score: 0.049
  23. Persistence of ZIKV-RNA in the cellular fraction of semen is accompanied by a surrogate-marker of viral replication. Diagnostic implications for sexual transmission. New Microbiol. 2018 Jan; 41(1):30-33.
    View in: PubMed
    Score: 0.046
  24. Human Zika infection induces a reduction of IFN-? producing CD4 T-cells and a parallel expansion of effector Vd2 T-cells. Sci Rep. 2017 07 24; 7(1):6313.
    View in: PubMed
    Score: 0.045
  25. Travel-Associated Zika Virus Disease. Ann Intern Med. 2017 06 20; 166(12):913.
    View in: PubMed
    Score: 0.045
  26. Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient. PLoS Pathog. 2017 01; 13(1):e1006065.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.